share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

週四盤後交易時段，12只醫療保健股走勢
Benzinga ·  2023/07/14 05:38

Gainers

獲勝者

  • Ainos (NASDAQ:AIMD) shares increased by 84.9% to $1.35 during Thursday's after-market session. At the close, Ainos's trading volume reached 264.0K shares. This is 3178.7% of its average volume over the last 100 days. The company's market cap stands at $27.0 million.
  • ACADIA Pharmaceuticals (NASDAQ:ACAD) shares increased by 18.6% to $30.6. ACADIA Pharmaceuticals's trading volume hit 984.3K shares by close, accounting for 74.3% of its average volume over the last 100 days. The company's market cap stands at $4.9 billion.
  • GT Biopharma (NASDAQ:GTBP) stock moved upwards by 17.4% to $0.33. GT Biopharma's trading volume hit 1.8 million shares by close, accounting for 375.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $12.3 million.
  • Centessa Pharmaceuticals (NASDAQ:CNTA) shares rose 15.24% to $8.62. The market value of their outstanding shares is at $824.1 million.
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE) stock rose 8.21% to $0.36. The market value of their outstanding shares is at $19.1 million.
  • Eterna Therapeutics (NASDAQ:ERNA) shares increased by 7.05% to $2.73. The market value of their outstanding shares is at $14.3 million.
  • 艾諾斯 納斯達克股票代碼：AIMD）的股價在週四的盤後交易時段上漲了84.9％，至1.35美元。收盤時，Ainos的交易量達到26.4萬股。這是其過去100天平均成交量的3178.7％。該公司的市值爲2700萬美元。
  • 阿卡迪亞製藥 納斯達克股票代碼：ACAD）的股價上漲了18.6％，至30.6美元。截至收盤，ACADIA Pharmicals的交易量達到984.3萬股，佔其過去100天平均交易量的74.3％。該公司的市值爲49億美元。
  • GT 生物製藥 納斯達克股票代碼：GTBP）股價上漲17.4％，至0.33美元。截至收盤，GT Biopharma的交易量達到180萬股，佔其過去100天平均交易量的375.4％。他們已發行股票的市值爲1,230萬美元。
  • 森特薩製藥 納斯達克股票代碼：CNTA）股價上漲15.24％，至8.62美元。他們已發行股票的市值爲8.241億美元。
  • Zynerba 製藥 納斯達克股票代碼：ZYNE）股價上漲8.21％，至0.36美元。他們已發行股票的市值爲1,910萬美元。
  • Eterna 療法 納斯達克股票代碼：ERNA）股價上漲7.05％，至2.73美元。他們已發行股票的市值爲1,430萬美元。

Losers

失敗者

  • Theseus Pharmaceuticals (NASDAQ:THRX) shares fell 71.4% to $2.72 during Thursday's after-market session. At the close, Theseus Pharmaceuticals's trading volume reached 2.9 million shares. This is 1828.0% of its average volume over the last 100 days. The company's market cap stands at $118.5 million.
  • Petros Pharma (NASDAQ:PTPI) stock declined by 10.46% to $3.17. At the close, Petros Pharma's trading volume reached 111.6K shares. This is 3.8% of its average volume over the last 100 days. The company's market cap stands at $6.7 million.
  • Molecular Templates (NASDAQ:MTEM) stock fell 10.28% to $0.46. This security traded at a volume of 838.7K shares come close, making up 726.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $25.7 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) stock decreased by 9.85% to $0.27. Bluejay Diagnostics's trading volume hit 60.5K shares by close, accounting for 4.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $5.5 million.
  • Adamis Pharmaceuticals (NASDAQ:ADMP) stock fell 8.12% to $2.15. The market value of their outstanding shares is at $5.7 million.
  • Aridis Pharmaceuticals (NASDAQ:ARDS) shares fell 6.89% to $0.33. This security traded at a volume of 334.5K shares come close, making up 8.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $11.9 million. See Also:
  • 修斯製藥 納斯達克股票代碼：THRX）股價在週四的盤後交易時段下跌71.4％，至2.72美元。收盤時，Theseus Pharmicals的交易量達到290萬股。這是其過去100天平均成交量的1828.0％。該公司的市值爲1.185億美元。
  • 彼得羅斯製藥 納斯達克股票代碼：PTPI）股價下跌10.46％，至3.17美元。收盤時，Petros Pharma的交易量達到11.16萬股。這是其過去 100 天平均交易量的3.8％。該公司的市值爲670萬美元。
  • 分子模板 納斯達克股票代碼：MTEM）股價下跌10.28％，至0.46美元。該證券的交易量接近83.87萬股，佔其過去100天平均成交量的726.6％。他們已發行股票的市值爲2570萬美元。
  • 藍鳥診斷 納斯達克股票代碼：BJDX）股價下跌9.85％，至0.27美元。收盤時，Bluejay Diagnostics的交易量達到60.5萬股，佔其過去100天平均交易量的4.3％。他們已發行股票的市值爲550萬美元。
  • 亞當斯製藥 納斯達克股票代碼：ADMP）股價下跌8.12％，至2.15美元。他們已發行股票的市值爲570萬美元。
  • 阿里迪斯製藥 納斯達克股票代碼：ARDS）股價下跌6.89％，至0.33美元。該證券的交易量接近33.45萬股，佔其過去100天平均交易量的8.8％。他們的已發行股票的市值爲1190萬美元。 另請參閱：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成，並由編輯審閱。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論